Navigation Links
United Therapeutics Subsidiary Enters Into Contract With National Institutes of Health for Award of up to $45 Million to Support Glycobiology Antiviral Program
Date:10/10/2011

>About United Therapeutics Corporation

United Therapeutics is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. [uthr-g]

About Unither Virology

Unither Virology, LLC is a wholly-owned subsidiary of United Therapeutics Corporation. The company is the preclinical stage of developing a broad-spectrum antiviral drug to treat multiple viruses, such as dengue and influenza. Drug candidates have been shown to protect animals against multiple viruses, and the company is commencing a program to move toward potential clinical trials.

The company's glycobiology antiviral agents are being developed under a research agreement with the Oxford Glycobiology Institute. The antiviral agents consist of iminosugar molecules, which enter host cells and inhibit the chemical pathways that viruses use to fold their proteins. Because the iminosugars affect the host cell, rather than attacking the virus directly, they reduce the chance for drug-resistant virus strains to emerge. In laboratory tests, the iminosugar molecules have shown activity against several families of viruses. Unither Virology is conducting ongoing in vivo tests.

Forward-looking Statements

Statements included in this press release that are not historical in nature are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, among others, our expectations regarding the receipt of up to approximately $45 million in funding from NIH, the timing of any such funding, the prospects for future job creation and our ability to develop a broad-spectrum antiviral drug. These forward-looking statements are subject to certain risks and uncertainties, such as those described in our periodic and other reports filed with the Securities and Excha
'/>"/>

SOURCE United Therapeutics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Full-day "United Nations" Online Investor Conference: October 6th at RetailInvestorConferences.com
2. United Therapeutics Corporation Reports Second Quarter 2011 Financial Results
3. FDA Advisory Panel Unanimously Recommends Approval of EXCOR(R) Pediatric Ventricular Assist Device for Use in the United States
4. Daiichi Sankyo Selects Veeva CRM to Support Customer Engagement Initiatives in the United Kingdom
5. United Therapeutics Corporation To Announce Second Quarter 2011 Financial Results Before Market Open on Thursday, July 28, 2011
6. United Therapeutics Corporation Completes Enrollment of FREEDOM-C(2) Trial
7. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
8. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
9. United Therapeutics Corporation Reports Third Quarter 2010 Financial Results
10. United Therapeutics Corporation to Announce Third Quarter 2010 Financial Results Before Market Open on Thursday, October 28, 2010
11. Sangart, Inc. Receives $1.1 Million Grant Award from the United States Department of Defense for Further Development of MP4 Molecule in Trauma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 2014 Deep Knowledge Ventures last ... on ‘Commercialising Longevity Research’ and welcomed a host ... London Bioscience Innovation Center for the event, organised ... Analytics Ltd. The meeting highlighted the need for ... for age-related disease, as well as the crucial ...
(Date:7/10/2014)... OMICS Group’s 5th International conference and ... 2014 at Double Tree by Hilton Beijing, China is ... Analytical & Bioanalytical research methods only to facilitate improved ... occasion, Dr. Srinubabu Gedela, MD of OMICS Group Inc ... remarkable one in bringing a unique and international mix ...
(Date:7/10/2014)... Capital, a firm specializing in acquiring and managing food ... the Slim-Fast brand from Unilever. Unilever will retain a ... were not disclosed. Slim-Fast is a branded ... shakes, powders, bars and snacks to retail customers throughout ... United Kingdom and Ireland.  The ...
(Date:7/10/2014)... help in the fight against terrorism with the creation ... explosives with the use of light and special glass ... Actuators B: Chemical , the researchers describe a novel ... as low as 6.3 ppm (parts per million). It ... , "Traditionally explosives detection has involved looking for metals ...
Breaking Biology Technology:DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Kainos Capital Acquires Slim-Fast From Unilever 2Detecting trace amounts of explosives with light 2
... Corp. said it has bought all outstanding stock ... handles bank transactions and check image processing. , ,Metavante, ... said in October that it would buy VectorSGIs stock ... wholly owned subsidiary. The move followed Metavantes acquisition of ...
... Jim Doyle, right, is joined by Commerce Sec. Cory ... Wis. Wisconsins Department of Commerce will fund ... and other assistance at centers around the state, Governor ... provide $1 million per year for five years, he ...
... U.S. Supreme Court made a patent-law decision on Monday that ... sector. , ,The court denied an appeal in Univ. ... solidifies the decision that was made by the U.S. Court ... patent because the inventor did not provide an adequate written ...
Cached Biology Technology:State and university form network for entrepreneurial outreach 2State and university form network for entrepreneurial outreach 3Describe your invention, or your biotech patent may be worthless 2Describe your invention, or your biotech patent may be worthless 3Describe your invention, or your biotech patent may be worthless 4Describe your invention, or your biotech patent may be worthless 5
(Date:7/11/2014)... under the normal circumstances, astrocytes participate in ... environment, and exhibit therapeutic and repairing effects ... studies have found that nerve cells differentiated ... have reduced viability, which produces influences on ... Kailuan General Hospital, Hebei United University, China ...
(Date:7/11/2014)... July 11, 2014 Research and Markets ... Biometrics Technology Market - Industry Analysis Size Share Growth ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... has created a need for high level security in ... personnel authentication such as username and passwords, tokens etc. ...
(Date:7/11/2014)... Rio de Janeiro, Brazil- In the brains of ... mechanism that allows an electric or chemical signal ... another. Chemical synapses, which are the most abundant ... inhibitory. Synapse formation is crucial for learning, memory, ... and inhibitory synapses critical for brain function. ...
Breaking Biology News(10 mins):International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2Blame it on the astrocytes 2
... number one killer in the world and India carries more ... set to rise: it is predicted that by 2010 India,s ... Today, an international team of 25 scientists from four countries ... the world,s population carries a mutation almost guaranteed to lead ...
... of yeast cells has resulted in the most detailed ... a Texas A&M University chemical engineering professor whose findings ... until now have remained mostly theory., Working with populations ... Katy Kao, assistant professor in the Artie McFerrin Department ...
... new, international competition called the Digging into Data ... the Joint Information Systems Committee (JISC) from the ... (NEH) and the National Science Foundation (NSF) from ... Humanities Research Council (SSHRC) from Canada. ...
Cached Biology News:The heart disease mutation carried by 60 million 2Evolutionary process more detailed than previously believed, study shows 2Evolutionary process more detailed than previously believed, study shows 3Evolutionary process more detailed than previously believed, study shows 4Leading research agencies announce new international competition: "The digging into data challenge" 2
... gun low-pressure system, 220-240 V, is used for ... handheld device employs an adjustable helium pulse to ... from the inner wall of a small plastic ... be used for in situ, in vitro, in ...
... Hybridization Wash Pack provides optimized blocking ... Preparation Quality Clarifier: Ready-to-use wash solutions ... SigmaScreen(tm) APS Coated Slides for Microarrays ... Hybridization Blocking Buffer: 1L • Microarray ...
Mouse polyclonal antibody raised against a partial recombinant MHC2TA. NCBI Entrez Gene ID = 4261...
Mouse monoclonal antibody raised against a partial recombinant JRKL. NCBI Entrez Gene ID = JRKL...
Biology Products: